Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,353 | -5,216 | -5,933 | -921 | 305 |
| Depreciation Amortization | 2,533 | 2,165 | 1,305 | 624 | 248 |
| Other Working Capital | 688 | 1,321 | -741 | 1,245 | 112 |
| Other Operating Activity | -1,924 | -190 | 0 | 0 | 0 |
| Operating Cash Flow | $-7,056 | $-1,920 | $-5,369 | $948 | $665 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,586 | -2,379 | -2,793 | -4,085 | -474 |
| Net Acquisitions | 0 | -42,241 | N/A | N/A | N/A |
| Other Investing Activity | 8,428 | 53 | -20,535 | -46,132 | 2,785 |
| Investing Cash Flow | $4,842 | $-44,567 | $-23,328 | $-50,217 | $2,311 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,460 | 45,928 | 30,021 | 47,996 | 98 |
| Financing Cash Flow | $1,460 | $45,928 | $30,021 | $47,996 | $98 |
| Beginning Cash Position | 5,440 | 5,999 | 4,675 | 5,947 | 2,873 |
| End Cash Position | 4,686 | 5,440 | 5,999 | 4,675 | 5,947 |
| Net Cash Flow | $-754 | $-559 | $1,324 | $-1,273 | $3,074 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,056 | -1,920 | -5,369 | 948 | 665 |
| Free Cash Flow | -7,056 | -1,920 | -5,369 | 948 | 665 |